SMO and neoplasm: Hh ligand expression was shown to be restricted to epithelial carcinoma cells, whereas increased expressions of the Patched-1 (PTCH1) receptor and Gli1, a downstream mediator of Smo signalling, were detected in the tumour-associated stroma of mouse pancreatic tumour models [56].